Company intelligence / Profile preview

Pierre Andurand

Dubai, Dubai, United Arab Emirates

Ownership: Private
Employees: ~24
Development stage: Other

Overview

Andurand Capital is a premier commodities-focused hedge fund management firm founded by renowned oil trader Pierre Andurand. While primarily specializing in energy markets, including oil, gas, and metals, the firm gained significant attention in the life sciences sector for its data-driven analysis of the COVID-19 pandemic to forecast market shifts. Pierre Andurand personally supports biotechnology research, notably as a donor to Imperial College London's self-amplifying RNA (saRNA) vaccine platform and as an independent board member of Plasticell, a stem cell technology company. The firm also manages the Andurand Climate and Energy Transition Fund, focusing on the global shift toward green energy.

Industry: Investors

Beyond the preview

Go deeper on Pierre Andurand.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pierre Andurand.

Explore the full profile